Gan & Lee Pharmaceuticals: Diabetes Mellitus, Type 2 trials
The registry lists 14 Diabetes Mellitus, Type 2 studies with Gan & Lee Pharmaceuticals as lead sponsor. 4 are open to participants now and 1 have results posted.
Phase 1 4Phase 2 7Phase 3 4(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Evaluate the Efficacy and Safety of GZR33 Injection in Patients With Type 2 DiabetesRecruitingNCT07527078Phase 3
- Evaluate the Efficacy and Safety of GZR101-80 Injection in Patients With Type 2 DiabetesNot yet recruitingNCT07387003Phase 2
- Comparison Study of Insulin GZR4 With Insulin DegludecRecruitingNCT07146347Phase 1
- A Trial Comparing Efficacy, Tolerability, and Safety of GZR101 Injection Once Daily (OD) and GZR33-70 Injection ODRecruitingNCT06558708Phase 2
- Gan & Lee Insulin Glargine Target Type (2) Evaluating ResearchCompletedNCT03371108Phase 3Results posted
- A Study to Compare the Efficacy and Safety of GZR102 Injection and GZR18 Injection in Type 2 Diabetes MellitusActive, not recruitingNCT07055386Phase 2
- A Phase III Clinical Study to Evaluate the Efficacy and Safety of GZR18 Injection in Adult Type 2 Diabetes MellitusActive, not recruitingNCT06778967Phase 3
- A Phase III Clinical Study to Evaluate the Efficacy and Safety of GZR18 Injection in Subjects With Type 2 Diabetes Mellitus and Poor Blood Glucose Control by Diet and ExerciseActive, not recruitingNCT06777238Phase 3
- A Study of GZR18 Tablet in Chinese Healthy SubjectsActive, not recruitingNCT06554054Phase 1
- A Study of GZR18 Injection in Chinese Patients With Type 2 Diabetes MellitusActive, not recruitingNCT06256549Phase 2
- A Study of GZR18 Injection in Chinese Adult Patients With Type 2 Diabetes Mellitus (T2DM)CompletedNCT06256523Phase 1/2
- A Trial Comparing the Efficacy and Safety of GZR4 Injection Versus Insulin Degludec in Subjects with Type 2 Diabetes MellitusCompletedNCT06202079Phase 2
- A Trial Comparing Efficacy and Safety of GZR101 and IDegAsp in Insulin Naïve or Insulin Treated Subjects with T2DMCompletedNCT06199505Phase 2
- Single, Ascending Dose, First Time in Human Study for GZR18 in Healthy SubjectsCompletedNCT05328726Phase 1